Now showing items 1-10 of 66
Systematic Review: The Effectiveness of Interventions to Reduce Falls and Improve Balance in Adults With Multiple Sclerosis.
OBJECTIVES: To evaluate the effectiveness of interventions in reducing falls and/or improving balance as a falls risk in multiple sclerosis (MS). DATA SOURCES: Computer-based and manual searches included the following ...
INTRA-RATER RELIABILITY OF THE MULTIPLE SINGLE-LEG HOP-STABILIZATION TEST AND RELATIONSHIPS WITH AGE, LEG DOMINANCE AND TRAINING.
BACKGROUND: Balance is a complex construct, affected by multiple components such as strength and co-ordination. However, whilst assessing an athlete's dynamic balance is an important part of clinical examination, there is ...
A Pilot RCT Investigating the Effects of Targeted Compression on Athletes with Pelvic / Groin Pain
(Human Kinetics, 2017-11)
Sensory–motor rehabilitation therapy for task-specific focal hand dystonia: A feasibility study
© 2018, The Author(s) 2018. Introduction: Medical treatments have limited long-term effect in task-specific dystonia. Whilst evidence supports the use of rehabilitation, no randomised controlled trials have been undertaken. ...
Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study.
(SAGE Publications, 2018-12-04)
OBJECTIVE:: To examine the feasibility of a trial to evaluate web-based physiotherapy compared to a standard home exercise programme in people with multiple sclerosis. DESIGN:: Multi-centre, randomized controlled, feasibility ...
Beyond current research practice: Methodological considerations in MS rehabilitation research (is designing the perfect rehabilitation trial the Holy Grail or a Gordian knot?)
(SAGE Publications, 2019-09-01)
<jats:p> Rehabilitation is an essential aspect of symptomatic and supportive treatment for people with multiple sclerosis (MS). The number of randomised controlled trials (RCTs) for rehabilitation interventions in MS has ...
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Disease-modifying drugs have mostly failed as treatments for progressive multiple sclerosis. Management of the disease therefore solely aims to minimise symptoms and, if possible, improve function. The degree to which this ...